FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bao Hoang

Research Profile

Disorders

Multiple Myeloma

Chemicals & Drugs

Anatomy

Tumor Cell Line

Living Beings

Physiology

Mutation

Procedures

Transplantation, Heterologous

Co-author Network

Publications

TOP 3
Patrick Frost; Joseph Gera; Bao Hoang; Veena Mysore; Yijiang Shi; Eileen Berlanger; Alan Lichtenstein
Mammalian target of rapamycin inhibitors induce tumor cell apoptosis in vivo primarily by inhibiting VEGF expression and angiogenesis.
Bao Hoang; Angelica Benavides; Patrick Frost; Joseph Gera; Yijiang Shi; Yonghui Yang; Alan Lichtenstein
The PP242 mammalian target of rapamycin (mTOR) inhibitor activates extracellular signal-regulated kinase (ERK) in multiple myeloma cells via a target of rapamycin complex 1 (TORC1)/eukaryotic translation initiation factor 4E (eIF-4E)/RAF pathway and activation is a mechanism of resistance.
Yijiang Shi; Patrick Frost; Bao Hoang; Angelica Benavides; Joseph Gera; Alan Lichtenstein
IL-6-induced enhancement of c-Myc translation in multiple myeloma cells: critical role of cytoplasmic localization of the rna-binding protein hnRNP A1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bao Hoang (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Patrick Frost; Joseph Gera; Bao Hoang; Veena Mysore; Yijiang Shi; Eileen Berlanger; Alan Lichtenstein
Mammalian target of rapamycin inhibitors induce tumor cell apoptosis in vivo primarily by inhibiting VEGF expression and angiogenesis.
Journal of oncology 2013;2013():897025.
2012: Bao Hoang; Angelica Benavides; Patrick Frost; Joseph Gera; Yijiang Shi; Yonghui Yang; Alan Lichtenstein
The PP242 mammalian target of rapamycin (mTOR) inhibitor activates extracellular signal-regulated kinase (ERK) in multiple myeloma cells via a target of rapamycin complex 1 (TORC1)/eukaryotic translation initiation factor 4E (eIF-4E)/RAF pathway and activation is a mechanism of resistance.
The Journal of biological chemistry 2012;287(26):21796-805.
2011: Yijiang Shi; Patrick Frost; Bao Hoang; Angelica Benavides; Joseph Gera; Alan Lichtenstein
IL-6-induced enhancement of c-Myc translation in multiple myeloma cells: critical role of cytoplasmic localization of the rna-binding protein hnRNP A1.
The Journal of biological chemistry 2011;286(1):67-78.
2010: Bao Hoang; Patrick Frost; Yijiang Shi; Eileen Belanger; Angelica Benavides; Gholam Pezeshkpour; Susanna Cappia; Tommasina Guglielmelli; Joseph Gera; Alan Lichtenstein
Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor.
Blood 2010;116(22):4560-8.
2009: Bao Hoang; Angelica Benavides; Yijiang Shi; Patrick Frost; Alan Lichtenstein
Effect of autophagy on multiple myeloma cell viability.
Molecular cancer therapeutics 2009;8(7):1974-84.
2007: Patrick Frost; Yijiang Shi; Bao Hoang; Alan Lichtenstein
AKT activity regulates the ability of mTOR inhibitors to prevent angiogenesis and VEGF expression in multiple myeloma cells.
Oncogene 2007;26(16):2255-62.
2006: Bao Hoang; Li Zhu; Yijiang Shi; Patrick Frost; Huajun Yan; Sanjai Sharma; Sherven Sharma; Lee Goodglick; Steven M Dubinett; Alan Lichtenstein
Oncogenic RAS mutations in myeloma cells selectively induce cox-2 expression, which participates in enhanced adhesion to fibronectin and chemoresistance.
Blood 2006;107(11):4484-90.
2006: Huajun Yan; Patrick Frost; Yijiang Shi; Bao Hoang; Sanjai Sharma; Myrna Fisher; Joseph Gera; Alan Lichtenstein
Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis.
Cancer research 2006;66(4):2305-13.
2004: Patrick Frost; Farhad Moatamed; Bao Hoang; Yijiang Shi; Joseph Gera; Huajun Yan; Philip Frost; Jay Gibbons; Alan Lichtenstein
In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model.
Blood 2004;104(13):4181-7.
2004: Jung-hsin Hsu; Yijiang Shi; Patrick Frost; Huajun Yan; Bao Hoang; Sanjai Sharma; Joseph Gera; Alan Lichtenstein
Interleukin-6 activates phosphoinositol-3' kinase in multiple myeloma tumor cells by signaling through RAS-dependent and, separately, through p85-dependent pathways.
Oncogene 2004;23(19):3368-75.
2002: Yuhong Song; Bao Hoang; David D Chang
ROCK-II-induced membrane blebbing and chromatin condensation require actin cytoskeleton.
Experimental cell research 2002;278(1):45-52.
2002: David D Chang; Bao Hoang; Jenny Liu; Timothy A Springer
Molecular basis for interaction between Icap1 alpha PTB domain and beta 1 integrin.
The Journal of biological chemistry 2002;277(10):8140-5.